Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Floriane Lachkar"'
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 4, p 792 (2021)
Non-alcoholic fatty liver disease is one of the most common chronic liver diseases, ranging from simple steatosis to steatohepatitis, fibrosis, and cirrhosis. Its prevalence is rapidly increasing and presently affects around 25% of the general popula
Externí odkaz:
https://doaj.org/article/65d47c54f7bf4c9da26428cd66ee2883
Publikováno v:
Biologie Aujourd’hui. 214:15-23
Les stéatopathies métaboliques sont des pathologies en pleine expansion car très associées à l’obésité. Elles englobent un éventail de troubles hépatiques allant de la stéatose à la stéatohépatite non alcoolique (NASH) pouvant conduire
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 792, p 792 (2021)
Journal of Clinical Medicine
Journal of Clinical Medicine, 2021, 10 (4), pp.792. ⟨10.3390/jcm10040792⟩
Journal of Clinical Medicine, MDPI, 2021, 10 (4), pp.792. ⟨10.3390/jcm10040792⟩
Journal of Clinical Medicine
Journal of Clinical Medicine, 2021, 10 (4), pp.792. ⟨10.3390/jcm10040792⟩
Journal of Clinical Medicine, MDPI, 2021, 10 (4), pp.792. ⟨10.3390/jcm10040792⟩
International audience; Non-alcoholic fatty liver disease is one of the most common chronic liver diseases, ranging from simple steatosis to steatohepatitis, fibrosis, and cirrhosis. Its prevalence is rapidly increasing and presently affects around 2
Publikováno v:
AJP-Endocrinology and Metabolism
AJP-Endocrinology and Metabolism, American Physiological Society, 2020, Online ahead of print. ⟨10.1152/ajpendo.00330.2020⟩
AJP-Endocrinology and Metabolism, American Physiological Society, 2020, Online ahead of print. ⟨10.1152/ajpendo.00330.2020⟩
Dihydroceramides (DhCers) are a type of sphingolipids that for a long time were regarded as biologically inactive. They are metabolic intermediates of the de novo sphingolipid synthesis pathway, and are converted into ceramides (Cers) with the additi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f68f5c73dd4c0b63881e1913e4b1b3bd
https://www.hal.inserm.fr/inserm-03004653
https://www.hal.inserm.fr/inserm-03004653
Publikováno v:
Biologie aujourd'hui. 214(1-2)
Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent pathology associated with obesity. It encompasses a spectrum of hepatic disorders ranging from steatosis to non-alcoholic steatohepatitis (NASH), which may lead to cirrhosis and hepatoce